Metraipolis › archive › dc_64637857ef8d

Comparing and combining xevinapant with ATR and PARP inhibition for the radiosensitization of HPV-negative HNSCC cells — Europe PMC PMID:41673235

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41673235
DOI
10.1038/s41598-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-05T22:31:46.610Z
SHA-256 of the archived text
3af0d11f5d57267dc0b63b9606e9855ed0bf30937713434c0fd327b424091df3
Stable URL of this page
https://metraipolis.com/documento/dc_64637857ef8d

How to cite

Comparing and combining xevinapant with ATR and PARP inhibition for the radiosensitization of HPV-negative HNSCC cells — Europe PMC PMID:41673235 — Europe PMC (en), https://europepmc.org/article/MED/41673235 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_64637857ef8d (Metraipolis archive dc_64637857ef8d, sha256 3af0d11f5d57267dc0b63b9606e9855ed0bf30937713434c0fd327b424091df3)
BibTeX
@misc{dc64637857ef8d,
  title = {Comparing and combining xevinapant with ATR and PARP inhibition for the radiosensitization of HPV-negative HNSCC cells — Europe PMC PMID:41673235},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41673235},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_64637857ef8d; sha256 3af0d11f5d57267dc0b63b9606e9855ed0bf30937713434c0fd327b424091df3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41673235. Agents can read the archived copy with the MCP tool read_document.